Bronchiectasis & NTM Association Abstracts & Presentations
The following articles and presentations present research derived from the Bronchiectasis and NTM Research Registry.
2025
NYU Symposium
Geyer A, Brunton AE, Choate R, et al. Age, Sex and Microbiology in U.S. Bronchiectasis and NTM Research Registry Participants. Presented at the 2nd North American Bronchiectasis and NTM Symposium, December 1, NY, NY.
Geyer A, Brunton AE, Jakharia K, et.al. Computed Tomography Signs of Chronic Sinusitis and P. aeruginosa infection in Bronchiectasis: U.S. Bronchiectasis and NTM Research Registry Study. Presented at the 2nd North American Bronchiectasis and NTM Symposium, December 1, NY, NY.
Thornton C, Brunton AE, Geyer A, et al. The Impact of Proton Pump Inhibitor (PPI) Use on Exacerbation Rates in Patients with Bronchiectasis: An Analysis of the US Bronchiectasis and NTM Research Registry. Presented at the 2nd North American Bronchiectasis and NTM Symposium, December 1, NY, NY.
CHEST
Yi DS, Brunton AE, Naureckas ET, et. al. The Impact of Body Mass Index in Bronchiectasis and Non-Tuberculous Mycobacterium (NTM): Findings From the US Bronchiectasis and NTM Research Registry (US BRR). Presented at CHEST, October 19-22, Chicago, IL.
ERS
Choate R, Brunton AE, Aksamit T, et. al. Exploring the Overlapping Burden of Alpha-1 Antitrypsin Deficiency and Bronchiectasis: Insights from the US BRR
Engin L, Cabrera C, Hughes R, et.al. Assessing Exacerbation History and Bronchiectasis Management in the US Bronchiectasis and NTM Research Registry (BRR)
WBC
Thornton C, Brunton AE, Geyer A, et al. The Impact of Proton Pump Inhibitor (PPI) Use on Exacerbation Rates in Patients with Bronchiectasis: An Analysis of the US Bronchiectasis and NTM Research Registry. Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.
Feir C, Brunton AE, Choate R, et al. High frequency chest wall oscillation (HFCWO) data in the Bronchiectasis and Nontuberculous Mycobacteria (NTM) Research Registry (BRR). Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.
Henkle E, Brunton AE, Engin L, et al. Treatment patterns by exacerbation history in adults with bronchiectasis: data from the U.S. Bronchiectasis and NTM Research Registry. Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.
Feltzer J, McShane PJ, Zha BS, et. al. Sociodemographic Factors Associated with Health Outcomes in a Sample of the U.S. Bronchiectasis and Nontuberculous Mycobacteria Research Registry. Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.
ATS
Hughes R, Reid F, et. al. Characteristics of Infrequent or Frequent Exacerbators: Data from the Bronchiectasis Research Registry
Swenson C, Marmor M, Solomon GM, et. al. Inhaled Anticholinergics in Bronchiectasis: Prescribing Practices, Exacerbations, and Culture Data from the US Bronchiectasis and Nontuberculous Mycobacterium Research Registry
Poore T, Brunton AE, McShane PJ, et. al. Aspergillus SP. Positive Airway Samples in People with Non-CF Bronchiectasis Is Associated with Higher Biomarkers of Systemic TH2 Inflammation, Allergic Airway Disease, and Airway Co-infection
Grabauskas T, Brunton AE, Metersky ML, et. al. Association of Otitis and/or Rhinosinusitis and Pseudomonas Aeruginosa in Sputum of Patients with Non-cystic Fibrosis Bronchiectasis
Lenhan B, Ignatius E, Marmor M, et. al. Mycobacterium Xenopi: A Small Case Series of Patients in the Bronchiectasis Research Registry
Yohannes AM, Brunton A, Choate R, et. al. Baseline Dyspnea Associated with Risk for Severe Features of Bronchiectasis Phenotype in the US Bronchiectasis and Nontuberculous Mycobacterium Research Registry
2024
ERS
Choate R, McShane PJ, Marmor M, et. al. Multimorbidity in patients with bronchiectasis: results from the US Bronchiectasis and NTM Research Registry (US BRR)
McShane PJ, Locantore N, Choate R, et. al. Clinical features of bronchiectasis according to age in the US Bronchiectasis Research Registry
WBC
Choate R, Marmor M, Jakharia K, et.al. Characteristics Associated with Multimorbidity in Patients with Bronchiectasis: Results from the US Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.
Maselli DJ, Brunton AE, Choate R, et.al. The association of the eosinophilic bronchiectasis phenotype and non-tuberculous mycobacterial pulmonary disease: an analysis of the US Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.
Maselli DJ, Brunton AE, Choate R, et.al. The eosinophilic bronchiectasis phenotype: findings from the US Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.
Marmor M, Mirza A, Brunton AE, et.al. Insights into the Relationship Between Bronchiectasis Exacerbation and Rate of Decline in Spirometry: An Examination of a National Prospective. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.
Mirza A, Marmor M, Brunton AE, et.al. Spirometry trends in bronchiectasis: a detailed examination of pulmonary function patterns from the US bronchiectasis and NTM research registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.
Swenson C, Brunton AE, Jakharia K, et.al. Fractional excretion of nitric oxide measurements and respiratory symptom profile among patients with non-CF bronchiectasis – data from the U.S. Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.
Zha BS, Ieong M, Brunton AE, et.al. Nontuberculous Mycobacteria Isolation: Impact of Inhaled Mucolytic Therapy in Patients with Bronchiectasis. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.
ATS
Prieto M, Brunton AE, Swenson C, et.al. Comparison of the Clinical Features of Bronchiectasis Patients with and Without a History of Tobacco Use - Data from the National Bronchiectasis and NTM Research Registry Consortium
Felzer JR, Chalmers S, Brunton AE, et. al. US Bronchiectasis and NTM Research Registry: Pseudomonas Treatment Patterns in Non-Cystic Fibrosis Bronchiectasis by Sociodemographic Factors
Marmor M, Brunton AE, Fraulino D, et.al. Association Between Nontuberculous Mycobacteria Isolation and Antibiotic Exposure
Vijaykumar K, Brunton AE, Chalmers S, et. al. Clinical Characterization of Patients With COPD- Bronchiectasis Overlap: Data From the US Bronchiectasis and NTM Research Registry
2023
WBC
McShane PJ, Brunton AE, Choate R, et. al. Prevalence and Factors Associated with the Isolation of Fungi in the Sputum of Bronchiectasis Patients
Marmor M, Brunton, AE, Choate, R et. al. Airway Pathogen Trends: A Look at the US Bronchiectasis Research Registry
Aksamit TR, Metersky ML, Locantore N, et. al. Bronchiectasis and NTM Research Registry: 5-year Mortality by BSI and FACED Severity Categories
Chalmers S, Felzer J, Brunton AE, et. al. Pseudomonas Treatment Practice Patterns and Outcomes in Non-Cystic Fibrosis Bronchiectasis: Analysis from the US Bronchiectasis and NTM Research Registry
ATS
Aksamit TR, Lapinel NC, Choate R, et.al. Association of Baseline and Subsequent Bronchiectasis Exacerbations in Patients From the US Bronchiectasis and NTM Research Registry (BRR)
Basavaraj A, Brunton AE, Choate R, et.al. Hypertonic Saline Use in Patients with Bronchiectasis: Analysis from the United States Bronchiectasis and NTM Research Registry
Lapinel N, Aksamit TR, Choate R, et.al. Longitudinal Changes in Forced Expiratory Volume 1 (FEV1) According to Exacerbation Frequency in Patients From the US Bronchiectasis and NTM Research Registry (BRR)
Maselli DJ, Brunton AE, Choate R, et.al. Clinical Features of Patients With an Eosinophilic Phenotype: An Analysis of the U.S Bronchiectasis and NTM Research Registry
McShane PJ, Swenson C, Richards C, et. al. Characteristics of Bronchiectasis Patients Who Tested Positive for Coronavirus Disease 2019 - Data From the United States Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease Research Registry
Richards C, Brunton AE, Choate R, et.al. CFTR Mutation and Increased Rates of Pulmonary Infections Among Patients From the US Bronchiectasis and NTM Research Registry
Sullivan L, Brunton AE, Choate R, et.al. Clinical Features of Bronchiectasis Patients With Rheumatoid Arthritis: An Analysis of the Bronchiectasis Research Registry
2022
CHEST
McShane PJ, Choate R, Lapinel, N, et. al. Clinical and microbiologic features in bronchiectasis patients with autoimmunity in the US Bronchiectasis and NTM Research Registry
Shah T, Metersky M, Brunton AE, et, al. Pseudomonas acquisition & long-term macrolide use in patients from the US Bronchiectasis and NTM Research Registry
ERS
Lapinel N, Choate R, Aksamit TR, et. al. Characteristics of frequent exacerbators in the US Bronchiectasis and NTM Research Registry
Aksamit TR, Lapinel N, Choate R, et. al. Longitudinal analysis of bronchiectasis exacerbations (BEx) in patients from the US Bronchiectasis and NTM Research Registry
Drysdale M, Choate R, Lininger N, et. al. Epidemiology of non-tuberculous mycobacterial (NTM) infections in bronchiectasis patients using the US Bronchiectasis/NTM Research Registry
ATS
Kang CJ, Choate R, Metersky ML, et.al. Bronchiectasis and Gender: Results from the National Bronchiectasis and NTM Research Registry
Lapinel N, Choate R, Aksamit TR, et.al. Gastroesophageal Reflux Disease (GERD) and Pulmonary Exacerbation Frequency in Bronchiectasis Patients from the Bronchiectasis and NTM Research Registry (BRR)
Lapinel N, Choate R, Aksamit TR, et.al. Nontuberculous Mycobacteria (NTM) Isolation Status Relative to Pulmonary Exacerbation Frequency in Bronchiectasis Patients: Results from the Bronchiectasis and NTM Research Registry (BRR)
2021
CHEST
Aksamit TR, Choate R, Mannino D, et.al. Descriptive Analysis from the United States Bronchiectasis and NTM Research Registry
ATS
Choate R, Metersky ML, Johnson MM, et al. Racial, Ethnic, and Socioeconomic Disparities in Treatment and Outcomes of Patients with Bronchiectasis and Nontuberculous Mycobacteria (NTM)
2020
ATS
Ku JH, Henkle E, Metersky ML, et al. Pulmonary Nontuberculous Mycobacterial Infection in Patients in the U.S. Bronchiectasis Research Registry: Use of Antibiotic Therapy and Adverse Events
Choate R, Aksamit TR, Addrizzo-Harris DJ, et al. Comparing Clinical Characteristics and Outcomes in Patients with Non-Cystic Fibrosis Bronchiectasis with Non-Tuberculous Mycobacteria and/or Pseudomonas Aeruginosa Within the US Bronchiectasis and NTM Research Registry
Metersky ML, Choate R, Addrizzo-Harris DJ, et al. The Association of Chronic Macrolide Treatment and Incident Isolation of Non-Tuberculous Mycobacteria in Patients with Bronchiectasis
2019
ATS
Ku JH, Chan B, Aksamit TR, et. al. The Validity of Claims-Based Codes to Identify Pseudomonas Infection in Patients with Bronchiectasis in Medicare Data
Choate R, Aksamit TR, Mannino DM, et. al. Pseudomonas Aeruginosa Associated with Severity of Non-Cystic Fibrosis Bronchiectasis Measured by the Modified Bronchiectasis Severity Score (BSI) and the FACED: The US Bronchiectasis and NTM Research Registry (BRR) Study
Basavaraj A, Choate R, Addrizzo-Harris DJ, et. al. Airway Clearance in Non-Cystic Fibrosis Bronchiectasis: Analysis from the United States Bronchiectasis Research Registry
2018
WBC
Aksamit TR, Brunton AE, Siegel, SA, et. al. Colonization with Pseudomonas Aeruginosa as a Predictor of Future Nontuberculous Mycobacteria Isolation
Metersky ML, Choate R. The Association of Stenotrophomonas Maltophilia with Patient Characteristics and Outcomes in Bronchiectasis
DiMango A, Choate R. Aspergillus Airway Colonization in Non-CF Bronchiectasis Patients is not Associated with Disease Severity
Despotes KA, Choate R, Daniels MLA, et.al. Markers of Non-Cystic Fibrosis Bronchiectasis Disease Severity and Nutrition in the United States Bronchiectasis Research Registry
Choate R, Mannino DM, Aksamit T. et al. Pseudomonas Aeruginosa Impact on Severity of Bronchiectasis
ATS
Choate R, Eden E, Addrizzo-Harris DJ, et. al. The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency, and Primary Ciliary Dyskinesia
2017
WBC
Pravosud V, Mannino DM, Choate R, et. al. Medication use as a measure of severity: Findings from the COPD Foundation NTM Social Survey
Pravosud V, Mannino DM, Choate R, et. al. Symptom burden among patients reporting nontuberculous mycobacteria (NTM): Findings from the COPD Foundation Survey
Choate R, Mannino DM, Aksamit T, et. al. Pseudomonas Aeruginosa Impact on Severity of Bronchiectasis
ATS
Aksamit TR, Choate R, O'Donnell AE, et. al. United States Bronchiectasis Registry Longitudinal Follow Up at Two Years
2015
ATS
Henkle E, Daley CL, Griffith DE, et. al. Patterns of Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis
2013
ATS
Winthrop KL, Aksamit T, Olivier K, et. al. The Respiratory Microbiology of Patients with Nontuberculous Mycobacteria from the United States Bronchiectasis Research Registry
Metersky M, O’Donnell A, Daley C, et. al. Staphylococcus aureus in Patients with non-CF Bronchiectasis: Results from the Bronchiectasis Research Registry
2012
ATS
Aksamit TR, Carretta E, Daley CL, et. al. The Bronchiectasis Research Registry: A Collaborative Research Cohort For Non-Cystic Fibrosis Bronchiectasis
2011
ATS
Czaja CA, Stewar D, Levin A, et. al. Prevalence and Clinical Significance of Mucoid Pseudomonas Aeruginosa Infection in Adults with Non-Cystic Fibrosis Bronchiectasis - Results From The Bronchiectasis Research Registry
Stewart D, LaVange L, Thomashow B, et. al. The Added Perspective of Changes Over Time, A Resource for Collaborative Research in Non-Cystic Fibrosis Bronchiectasis
2010
ATS
LaVange L, Stewart D, Thomashow B, et. al. The Bronchiectasis Research Registry: a Resource for Collaborative Research in non-Cystic Fibrosis Bronchiectasis
O'Connell ML, Prevots DR, Olivier KN, et. al. The Bronchiectasis Research Registry: Clinical, Microbiologic, and Treatment Characteristics